Review Article
Emerging Approaches of Transcatheter Valve Repair/Insertion
Table 1
Clinical characteristics of patients presenting for transcatheter aortic valve implantation.
| | Transfemoral | Transapical | Transaxillary | value |
| Patients | 107 | 15 | 15 | | Edwards-Sapien, (%) | 61 (57) | 15 (100) | 3 (20) | .0001 | CoreValve, (%) | 46 (43) | | 12 (80) | .0001 | Age (years) | 79.7 ± 7 | 78.8 ± 6.5 | 78.7 ± 5 | .794 | Male, (%) | 56 (52) | 5 (33) | 12 (80) | .034 | Diabetes, (%) | 31 (29) | 4 (26.7) | 5 (33) | .917 | Chronic kidney disease, (%) | 39 (36.4) | 5 (33) | 7 (46.7) | .706 | Porcelain aorta, (%) | 17 (15.9) | 14 (93.3) | 7 (46.7) | .0001 | COPD, (%) | 46 (43) | 6 (40) | 11 (73) | .077 | Previous myocardial infarction, (%) | 29 (27) | 5 (33) | 6 (40) | .549 | Cerebrovascular disease, (%) | 20 (18.7) | 8 (53) | 3 (20) | .011 | Peripheral vascular disease, (%) | 26 (24.3) | 10 (67.7) | 12 (80) | .0001 | NYHA functional class III-IV, (%) | 75 (70) | 11 (73.3) | 9 (60) | .685 | Logistic EuroSCORE, mean ± SD | 26.6 ± 16 | 32.2 ± 23 | 28.6 ± 14 | .477 | STS-PROM score, mean ± SD | 7 ± 4.9 | 8.3 ± 4.2 | 6.9 ± 2.8 | .602 | Mean aortic gradient (mmHg), mean ± SD | 54 ± 17.2 | 44.7 ± 18 | 47.7 ± 14.9 | .074 | LVEF (%), mean ± SD | 50.8 ± 12.9 | 50 ± 12.5 | 52.8 ± 11 | .814 |
|
|
COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association; LVEF: left ventricle ejection fraction.
|